Stay updated on Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.

Latest updates to the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedNew navigation options 'Check who can join' and 'Find Contact Information' were added to the study record history, enhancing access to enrollment eligibility and contact details. The revision history was updated to reflect version v3.6.0, with the previous v3.5.5 entry removed.SummaryDifference0.6%

- Check21 days agoChange DetectedThe record history gained a new revision entry (v3.5.5) and removed the previous revision (v3.5.4), updating the page's revision log.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision value v3.5.4 replaces the previous v3.5.3 on the Record History page, indicating an update to the page version. This update reflects administrative changes rather than user-facing content.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s footer shows an updated ClinicalTrials.gov site revision from v3.5.2 to v3.5.3, a change limited to the platform/version label rather than the trial information itself.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision v3.5.0 added and Revision v3.4.3 removed from the study's record history.SummaryDifference0.1%

Stay in the know with updates to Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.